Literature DB >> 15621867

Human herpes simplex virus keratitis: the pathogenesis revisited.

Lies Remeijer1, Albert Osterhaus, Georges Verjans.   

Abstract

Infections with several members of the human herpesviruses are the cause of significant ocular morbidity. Of the human herpesviruses, HSV-1 is the most frequent cause of primary and recurrent eye disease. Despite the availability of effective antiviral treatment, recurrent HSV-1 infection continues to be the leading cause of corneal blindness in industrialized nations. This review recapitulates the current insights in the role of the virus and the intra-corneal T cell response involved in the pathogenesis of human HSV-1-induced keratitis.

Entities:  

Mesh:

Year:  2004        PMID: 15621867     DOI: 10.1080/092739490500363

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  32 in total

1.  Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.

Authors:  Hui-Wen Yao; Shih-Heng Chen; Ching Li; Yuk-Ying Tung; Shun-Hua Chen
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells.

Authors:  Jayavardhana R Palem; Gautam R Bedadala; Khalid A El Sayed; Shao-chung V Hsia
Journal:  Planta Med       Date:  2010-07-19       Impact factor: 3.352

3.  Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes.

Authors:  Peter Norberg; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

4.  [Ping-pong transmission of herpes simplex virus 1 following corneal transplantation].

Authors:  E Stavridis; Z Gatzioufas; A Hasenfus; M Sauter; S Smola; B Seitz
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

5.  [Therapy refractory stromal Herpes keratitis under aciclovir].

Authors:  C Spira; N Szentmáry; A Hasenfus; M Sauter; S Smola; B Seitz
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

6.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

7.  Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Authors:  Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Ravinder Earla; Suman Sirimulla; Jake Brain Bailey; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2013-05-09       Impact factor: 4.200

Review 8.  Etiology and therapy of delayed facial paralysis after middle ear surgery.

Authors:  Jonas Eckermann; Jens Eduard Meyer; Thomas Guenzel
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-01       Impact factor: 2.503

9.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

10.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.